Application Nr Approved Date Route Status External Links
ANDA202555 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Mycophenolic Acid Is An Antimetabolite Immunosuppressant Indicated For Prophylaxis Of Organ Rejection In Adult Patients Receiving Kidney Transplants And In Pediatric Patients At Least 5 Years Of Age And Older Who Are At Least 6 Months Post Kidney Transplant. ( 1.1 ) Use In Combination With Cyclosporine And Corticosteroids. ( 1.1 ) Limitations Of Use: Mycophenolic Acid Delayed Release Tablets And Mycophenolate Mofetil Tablets And Capsules Should Not Be Used Interchangeably. ( 1.2 ) 1.1 Prophylaxis Of Organ Rejection In Kidney Transplant Mycophenolic Acid Delayed Release Tablets Are Indicated For The Prophylaxis Of Organ Rejection In Adult Patients Receiving A Kidney Transplant. Mycophenolic Acid Delayed Release Tablets Are Indicated For The Prophylaxis Of Organ Rejection In Pediatric Patients 5 Years Of Age And Older Who Are At Least 6 Months Post Kidney Transplant. Mycophenolic Acid Delayed Release Tablet Is To Be Used In Combination With Cyclosporine And Corticosteroids. 1.2 Limitations Of Use Mycophenolic Acid Delayed Release Tablets And Mycophenolate Mofetil (Mmf) Tablets And Capsules Should Not Be Used Interchangeably Without Physician Supervision Because The Rate Of Absorption Following The Administration Of These Two Products Is Not Equivalent.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Mycophenolate Sodium

Comments